OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reprogramming the immunosuppressive tumor microenvironment: exploiting angiogenesis and thrombosis to enhance immunotherapy
Areez Shafqat, Mohamed H. Omer, Eman Nayaz Ahmed, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11

Showing 11 citing articles:

How Neutrophils Shape the Immune Response: Reassessing Their Multifaceted Role in Health and Disease
Areez Shafqat, Jibran Ahmad Khan, Aghiad Yahya Alkachem, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17583-17583
Open Access | Times Cited: 27

The role of microRNAs in the gastric cancer tumor microenvironment
Xianzhe Yu, Yin Zhang, Fengming Luo, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 13

Enhancing cancer immunotherapy: Nanotechnology-mediated immunotherapy overcoming immunosuppression
Yunna Chen, Qianqian Zhou, Zongfang Jia, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3834-3854
Open Access | Times Cited: 12

Exploring Immune Checkpoint Inhibitors: Focus on PD-1/PD-L1 Axis and Beyond
Durre Aden, Samreen Zaheer, Niti Sureka, et al.
Pathology - Research and Practice (2025) Vol. 269, pp. 155864-155864
Closed Access

Nanoimmunotherapy: the smart trooper for cancer therapy
Suphiya Parveen, Dhanshree Vikrant Konde, Safal Kumar Paikray, et al.
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access

Anlotinib and anti-PD-1 mAbs perfected CIK cell therapy for lung adenocarcinoma in preclinical trials
Yingge Lv, Hua Zhao, Shaochuan Liu, et al.
Journal of Leukocyte Biology (2024) Vol. 116, Iss. 3, pp. 544-554
Open Access | Times Cited: 2

Triple therapy boosts survival in NSCLC patients with brain metastases: a retrospective cohort study of chemotherapy, ICIs, and antiangiogenic agents
Dingyi Yang, Erha Munai, Siwei Zeng, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 11
Open Access | Times Cited: 1

Targeting CD47 and Angiogenesis Demonstrates Effective Anti-Tumor Effect in Bladder Cancer
Xiting Huang, Qian Wang, Yanyang Nan, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 2152-2152
Open Access

Diagnostic predictive value of peripheral blood count and inflammatory markers in gastric cancer
hongyang sun, Jincheng Liu, Lu Liang
Research Square (Research Square) (2023)
Open Access

Page 1

Scroll to top